
Aspira Women's Health AWH
Aspira Women's Health ROCE | AWH
ROCE Jährlich Aspira Women's Health
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114.15 | 635.12 | 797.12 | -446.17 | -108.03 | -136.17 | -155.11 | -134.21 | -213.6 | -273.98 | -109.31 | -99.77 | -32.73 | -173.15 | -151.62 | -316.33 | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 797.12 | -446.17 | -50.24 |
ROCE Vierteljährlich Aspira Women's Health
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5539.25 | 5652.33 | 5734.42 | 6012.57 | 612.57 | 1237.16 | 1906.96 | 1029.14 | 683.58 | 606.82 | -75.96 | -936.86 | -177.49 | -202.66 | -143.14 | -96.18 | -53.65 | -97.7 | -111.9 | -133.76 | -122.51 | -166.57 | -171.79 | -174.99 | -135.89 | -172.84 | -171.16 | -161.53 | -118.97 | -192.32 | -224.23 | -259.8 | -220.16 | -312.27 | -338.89 | -400.18 | -322.22 | -351.53 | -287.06 | -211.38 | -81.23 | -110.26 | -109.81 | -102.93 | -78.64 | -87.3 | -66.19 | -47.04 | -26.29 | -75.53 | -145.54 | -183.99 | -174.27 | -217.97 | -222.76 | -187.03 | -140.66 | -43.7 | -54.03 | -42.93 |
Quartalsentwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 6012.57 | -936.86 | 337.85 |
ROCE anderer Aktien in der Diagnostik & Forschung
| Name | ROCE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | ||
|
Renalytix AI plc
RNLX
|
376.98 | - | 5.66 % | $ 22.7 M | ||
|
Psychemedics Corporation
PMD
|
-36.9 | - | -1.84 % | $ 15.3 M | ||
|
Meridian Bioscience
VIVO
|
13.43 | - | - | $ 1.49 B | ||
|
DexCom
DXCM
|
21.72 | $ 79.92 | -1.42 % | $ 31.2 B | ||
|
Quest Diagnostics Incorporated
DGX
|
21.7 | $ 258.38 | -0.5 % | $ 28.7 B | ||
|
Castle Biosciences
CSTL
|
-8.4 | $ 34.41 | 0.07 % | $ 997 M | ||
|
IDEXX Laboratories
IDXX
|
61.76 | $ 696.77 | -1.4 % | $ 56 B | ||
|
Illumina
ILMN
|
29.64 | $ 214.84 | -2.69 % | $ 33.3 B | ||
|
Anixa Biosciences
ANIX
|
-77.18 | $ 3.05 | -3.48 % | $ 99 K | ||
|
Biodesix
BDSX
|
-39.8 | $ 10.04 | -2.95 % | $ 75.8 M | ||
|
BioNano Genomics
BNGO
|
-65.83 | $ 1.25 | 7.66 % | $ 6.81 M | ||
|
Bioventus
BVS
|
11.27 | $ 11.18 | 1.5 % | $ 745 M | ||
|
Fulgent Genetics
FLGT
|
-8.03 | $ 25.83 | -1.22 % | $ 795 M | ||
|
CareDx, Inc
CDNA
|
-9.52 | $ 80.78 | -4.31 % | $ 4.3 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M | ||
|
Biomerica
BMRA
|
-202.28 | $ 1.48 | -4.52 % | $ 4.31 M | ||
|
Interpace Biosciences
IDXG
|
18.26 | $ 7.0 | -13.43 % | $ 31 M | ||
|
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | ||
|
ICON Public Limited Company
ICLR
|
3.39 | $ 204.62 | -1.43 % | $ 16 B | ||
|
Co-Diagnostics
CODX
|
-236.6 | $ 0.29 | -9.5 % | $ 386 K | ||
|
Burning Rock Biotech Limited
BNR
|
-9.56 | $ 13.19 | 6.46 % | $ 135 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | ||
|
DarioHealth Corp.
DRIO
|
-36.38 | $ 2.37 | 15.05 % | $ 9.44 M | ||
|
Myriad Genetics
MYGN
|
-67.6 | $ 5.66 | -1.39 % | $ 524 M | ||
|
ENDRA Life Sciences
NDRA
|
-185.74 | $ 4.78 | -1.24 % | $ 3.76 M | ||
|
QIAGEN N.V.
QGEN
|
8.07 | $ 50.52 | -0.07 % | $ 11 B | ||
|
NeoGenomics
NEO
|
-9.11 | $ 16.97 | -3.58 % | $ 2.17 B | ||
|
OPKO Health
OPK
|
-6.58 | $ 1.71 | 0.58 % | $ 1.28 B | ||
|
Pacific Biosciences of California
PACB
|
-77.87 | $ 2.22 | -5.93 % | $ 666 M | ||
|
Neogen Corporation
NEOG
|
-1.03 | $ 11.67 | -3.44 % | $ 2.54 B | ||
|
Precipio
PRPO
|
-6.84 | $ 23.56 | 6.13 % | $ 37.8 M | ||
|
Personalis
PSNL
|
-29.9 | $ 15.9 | -0.31 % | $ 1.42 B | ||
|
Sotera Health Company
SHC
|
10.33 | $ 16.25 | -1.16 % | $ 4.61 B | ||
|
Quidel Corporation
QDEL
|
69.35 | $ 11.56 | -4.43 % | $ 487 M | ||
|
Centogene N.V.
CNTG
|
-87.78 | - | -6.23 % | $ 30.6 M | ||
|
Trinity Biotech plc
TRIB
|
-29.73 | $ 5.88 | 10.08 % | $ 2.11 B | ||
|
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-119.91 | - | 0.12 % | $ 80.1 M | ||
|
Check-Cap Ltd.
CHEK
|
-69.04 | - | - | $ 9.42 M | ||
|
Exact Sciences Corporation
EXAS
|
-8.59 | - | - | $ 19.8 B | ||
|
National Research Corporation
NRC
|
22.99 | $ 26.91 | 0.9 % | $ 602 M | ||
|
Twist Bioscience Corporation
TWST
|
-28.81 | $ 132.17 | -2.35 % | $ 7.9 B | ||
|
Organovo Holdings
ONVO
|
1045.22 | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
75.43 | - | -16.95 % | $ 1.54 M | ||
|
PerkinElmer
PKI
|
3.29 | - | -0.91 % | $ 14.7 B | ||
|
Soleno Therapeutics
SLNO
|
1.87 | - | - | $ 2.69 B |